Company Description
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally.
It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems.
It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems.
In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures.
It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers.
The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa.
Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
| Country | United States |
| Founded | 1987 |
| IPO Date | Aug 9, 1990 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 7,500 |
| CEO | Martha Aronson |
Contact Details
Address: 1600 West Merit Parkway South Jordan, Utah 84095 United States | |
| Phone | 801 253 1600 |
| Website | merit.com |
Stock Details
| Ticker Symbol | MMSI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000856982 |
| CUSIP Number | 589889104 |
| ISIN Number | US5898891040 |
| Employer ID | 87-0447695 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Martha Goldberg Aronson | President, Chief Executive Officer and Director |
| Neil W. Peterson | Chief Operating Officer |
| Brian G. Lloyd J.D. | Chief Legal Officer and Corporate Secretary |
| Jason Treft | Chief Information Officer |
| Sarah Comstock | Vice President of Global Communications |
| John Knorpp | Chief Regulatory Affairs Officer |
| Ricardo Alvarez | Managing Director of Operation Merit Medical Tijuana |
| Mark Butler | Executive Vice President of Merit Medical EMEA |
| Alisha Jerauld | Sustainability Council Chair and Vice President of Environment, Social and Governance |
| Clay Creamer | Executive Vice President of Manufacturing Finance and Strategy |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 1, 2026 | 8-K | Current Report |
| Mar 31, 2026 | ARS | Filing |
| Mar 31, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 31, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 27, 2026 | SCHEDULE 13G/A | Filing |
| Feb 24, 2026 | 10-K | Annual Report |
| Feb 24, 2026 | 8-K | Current Report |
| Jan 8, 2026 | 8-K | Current Report |
| Jan 6, 2026 | 144 | Filing |
| Nov 25, 2025 | 144 | Filing |